ACADIA Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2834 http://www.acadia-pharm.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc. - Jun 13th, 2019 6:02 am
Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy? - Jun 11th, 2019 6:23 pm
When Will ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Turn A Profit? - Jun 11th, 2019 4:59 am
ACADIA Pharmaceuticals to Present at the Goldman Sachs 40th Annual Global Healthcare Conference - Jun 4th, 2019 7:00 am
ACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in Major Depressive Disorder at the 2019 American Psychiatric Association Annual Meeting - May 18th, 2019 9:00 am
Edited Transcript of ACAD earnings conference call or presentation 1-May-19 8:30pm GMT - May 9th, 2019 1:57 am
Why Acadia Pharmaceuticals Stock Slumped in April - May 8th, 2019 1:30 pm
ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019 - May 7th, 2019 7:00 am
Acadia Pharmaceuticals (ACAD) Q1 2019 Earnings Call Transcript - May 2nd, 2019 1:24 am
Acadia Pharmaceuticals (ACAD) Reports Q1 Loss, Tops Revenue Estimates - May 1st, 2019 5:35 pm
Acadia: 1Q Earnings Snapshot - May 1st, 2019 4:29 pm
ACADIA Pharmaceuticals Reports First Quarter 2019 Financial Results - May 1st, 2019 2:05 pm
Were Hedge Funds Right About Flocking Into ACADIA Pharmaceuticals Inc. (ACAD)? - Apr 29th, 2019 7:58 pm
Analysts point to potential Biogen M&A options after Alzheimer's failure - Apr 26th, 2019 4:10 am
ACADIA Pharmaceuticals Initiates Phase 3 CLARITY Program with Pimavanserin as Adjunctive Treatment for Major Depressive Disorder - Apr 25th, 2019 7:00 am
Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for - Apr 24th, 2019 8:33 am
Should ACADIA Pharmaceuticals (NASDAQ:ACAD) Be Disappointed With Their -30% Profit? - Apr 19th, 2019 7:11 am
ACADIA Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019 - Apr 17th, 2019 7:00 am